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Identity 
Other names: DFNB10 (deafness, autosomal recessive 
10); DFNB8 (deafness, autosomal recessive 8); 
TADG12 (Tumor associated differentially-expressed 
gene-12 protein); ECHOS1 
HGNC (Hugo): TMPRSS3 
Location: 21q22.3 
Note: Not to be confused with TMPRSS4 (11q23.3), 
which was originally named TMPRSS3. 
DNA/RNA 
Description 
13 exons spanning 24 kb. 
Transcription 
Four alternative splice isoforms have been described, 




Isoform A (full length) is 454 amino acids; isoforms B 
and C lack 127 aa at the N-terminus due to alternative 
splicing; isoform D is 344 aa and has a unique C-
terminus due to alternative splicing. The full length 
isoform comprises an LDL-receptor A domain, a 
Scavenger receptor (Srcr) domain and a peptidase S1 
S6 domain. 
Expression 










Insertion, frameshift and missense mutations in the 
TMPRSS3 gene have been described in familial 
congenital (DFNB10) and childhood onset (DFNB8) 
deafness. 
Implicated in 
Autosomal recessive neurosensory 
deafness; childhood-onset deafness 
(DFNB8); Autosomal recessive 




Variant D of TMPRSS3 has been reported to be 
overexpressed in ovarian carcinomas and has been 
proposed as a novel diagnostic marker. 
Prognosis 
High expression of variant D is correlated with 
advanced clinical stages of the disease. 
Pancreatic Cancer 
Disease 
TMPRSS3 has been reported to be overexpressed in 
pancreatic cancer. No information on splice variants or 
prognostic value is available. 
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